Mick Mulvaney, the former acting White House chief of staff, was tested twice for coronavirus despite exhibiting no symptoms, The Washington Post reports.
Mulvaney was first tested in February. He was scheduled to accompany President Trump on his visit to India, but prior to leaving said he felt sick. Although the test came back negative, Mulvaney did not join Trump on the trip. He was tested again this month after his niece, who shares an apartment with him, showed COVID-19 coronavirus symptoms after visiting Mar-a-Lago and meeting members of a Brazilian delegation who later tested positive for the virus, the Post reports.
During an appearance at the Conservative Political Action Conference (CPAC) in late February, Mulvaney tried to downplay the seriousness of COVID-19, saying it is "not a death sentence" and was being exaggerated because the media thinks "this will bring down the president."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In addition to Mulvaney, two other people close to Trump have been tested for coronavirus despite not showing any symptoms; Mark Meadows, his new acting White House chief of staff, and Rep. Matt Gaetz (R-Fla.). Gaetz and Meadows came into contact with a person at CPAC who was later diagnosed with COVID-19, and the White House medical office arranged their tests because of the possibility they could infect Trump, the Post says.
Federal health officials have said only people who are seriously ill should receive COVID-19 tests, and because of shortages, the United States is testing at a rate of just 0.12 percent, the Post reports. People who have been exposed to COVID-19 are being told to stay at home, take their temperature twice a day, and monitor for any symptoms. Read more at The Washington Post.
-
Quiz of The Week: 15 – 21 NovemberQuiz Have you been paying attention to The Week’s news?
-
Can the UK do more on climate change?Today's Big Question Labour has shown leadership in the face of fraying international consensus, but must show the public their green mission is ‘a net benefit, not a net cost’
-
The Week Unwrapped: Will US Catholics rebel against the Pope?Podcast Plus what are the ethics of freezing your late partner?
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
